Loading clinical trials...
Loading clinical trials...
Symptoms, Toxicity Prevalence and Quality of Life Benefit of Targeted Therapies and Immunotherapies in Lung Cancer Patients: An Observational Prospective Cohort Study Within the Total Cancer Care Population
Conditions
Interventions
No Intervention
Locations
1
United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Start Date
February 16, 2017
Primary Completion Date
August 18, 2018
Completion Date
November 19, 2021
Last Updated
February 27, 2023
NCT06043817
NCT05671510
NCT07177937
NCT06426511
NCT06257264
NCT03563976
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions